New blood test could predict deadly liver complications years in advance
NCT ID NCT07185360
Summary
This study aims to develop new blood tests that can predict which patients with early-stage liver scarring (cirrhosis) are at highest risk of developing liver failure or liver cancer. Researchers will analyze tiny particles in the blood called extracellular vesicles, along with other markers, to create these prediction tools. The goal is to help doctors better monitor patients and decide who needs more intensive care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bichat Hospital, Beaujon Hospital, Cochin Hospital and Lariboisière Hospital
Paris, France, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.